- Recent Funding
- Investors
- Addex Therapeutics
Addex Therapeutics portfolio
Addex Therapeutics has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Neurosterix's $63M Series A round in April 2024, alongside Xontogeny, Perceptive Advisors and Acorn Bioventures. That company is in Health and bio.
What Addex Therapeutics invests in
- Health and bio · 1 · 100%
How Addex Therapeutics invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $63M |
Addex Therapeutics portfolio companies
NNeurosterix$63MSeries A · Apr 2024
| Company | Round with Addex Therapeutics | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $63M | $168M | Nov 13, 2026 Series B+ |
Most frequent co-investors
PPerceptive Advisors1 shared round · last Apr 3, 2024
XXontogeny1 shared round · last Apr 3, 2024
AAcorn Bioventures1 shared round · last Apr 3, 2024
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Addex Therapeutics. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Addex Therapeutics, which is a subset of its real portfolio. API: /api/v1/investors/addex-therapeutics (get a free API key). More: the most active VC firms and new venture capital funds.